3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
47
Phase 1
25
Phase 1/2
22
Phase 3
10
Phase 2/3
3
Phase NA
2
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Leukemia, Myeloid, Acute
11
Neoplasm, Residual
3
Leukemia
3
Recurrence
2
Leukemia, Promyelocytic, Acute
2
Burkitt Lymphoma
2
Myelodysplastic Syndromes
1
Meningitis
1
Meningeal Neoplasms
1
Mediastinal Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia, Biphenotypic, Acute
1
Interventions
posaconazole
2
fludarabine
2
Cyclophosphamide
2
Busulfan
2
fludarabine phosphate
1
eltrombopag
1
Thiotepa
1
Radiotherapy
1
Peripheral Blood Stem Cell Transplantation
1
Micafungin
1
Idarubicin
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Decitabine
1
Cytarabine
1
Cholecalciferol
1
Bone Marrow Transplantation
1
Azacitidine
1
Antilymphocyte Serum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Myelodysplastic Syndromes
×
Cytarabine
×
Clear all
NCT00487448
2008-11-19
FLAG-IDA
PETHEMA Foundation
Phase 4
Completed
200 enrolled